ClinicalTrials.gov
ClinicalTrials.gov Menu

Mammography SPECT With Rotating Slant Hole Collimator

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00328354
Recruitment Status : Withdrawn (Ran out of time/ funding)
First Posted : May 19, 2006
Last Update Posted : April 6, 2018
Sponsor:
Information provided by (Responsible Party):
Johns Hopkins University

May 18, 2006
May 19, 2006
April 6, 2018
December 2006
December 2007   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00328354 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Mammography SPECT With Rotating Slant Hole Collimator
Not Provided
The goal is to conduct a pilot study to determine the feasibility of the clinical use of RMSSH SPECT imaging technology for breast imaging and to develop a standardized clinical protocol.
The goal of this protocol is to develop and evaluate a novel SPECT imaging technique for imaging the breast using rotating multi-segment slant-hole (RMSSH) collimators. The motivation is the requirement of a low cost RMSSH collimator and a conventional Large-Field-Of-View (LFOV) camera. It is believed that RMSSH SPECT is particularly suitable for applications in breast imaging.
Observational
Observational Model: Other
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Women seen at Johns Hopkins Avon Division of Breast Imaging who have been diagnosed with breast cancer.
Breast Cancer
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Withdrawn
0
20
December 2007
December 2007   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Women seen at Johns Hopkins Avon Division of Breast Imaging who have been diagnosed with breast cancer.

Exclusion Criteria:

  • Pregnant (or possibly pregnant)
  • Lactating
  • Unable to give consent
  • Weights over 300 pounds
  • Women who have already undergone definitive surgical treatment to their breast for breast cancer will not be eligible.
Sexes Eligible for Study: Female
35 Years to 80 Years   (Adult, Older Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00328354
R01 EB 0019-83 Mammography
Not Provided
Not Provided
Not Provided
Johns Hopkins University
Johns Hopkins University
Not Provided
Principal Investigator: Benjamin Tsui, Ph.D. Johns Hopkins University
Johns Hopkins University
April 2018